Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704860 | SCV000233340 | likely benign | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25758994) |
Labcorp Genetics |
RCV000226945 | SCV000283453 | likely benign | Ehlers-Danlos syndrome, type 4 | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001183976 | SCV000319422 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-07-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001183976 | SCV001349838 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-11-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330540 | SCV004038854 | likely benign | not specified | 2023-08-10 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001704860 | SCV004562108 | likely benign | not provided | 2023-09-22 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000226945 | SCV005427235 | likely benign | Ehlers-Danlos syndrome, type 4 | 2024-09-23 | criteria provided, single submitter | clinical testing |